Rare diseases
Investigational molecules
Locations
Back to the Netherlands31 clinical trials in Schiedam, The Netherlands. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)The NetherlandsThe NetherlandsThe NetherlandsThe NetherlandsThe NetherlandsThe NetherlandsThe NetherlandsThe NetherlandsThe NetherlandsThe NetherlandsThe NetherlandsThe NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on advanced solid tumors, particularly investigating new therapeutic approaches for prostate, breast, and renal cell cancers. Several studies explore combination therapies with novel agents.
Notable investigations include treatment options for metastatic disease and hormone-receptor-positive cancers.
Research centered on blood cancers, including innovative treatments for lymphomas, leukemia, and multiple myeloma. Studies evaluate targeted therapies and immunological approaches.
Emphasis on developing treatment-free intervals and maintenance therapies for better patient outcomes.
Studies exploring targeted therapies and immunological treatments across various cancer types. Focus on personalized medicine and biomarker-driven treatment selection.
Integration of molecular profiling and targeted approaches to enhance treatment efficacy.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
